Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.37
Delayed Data
As of Jan 20
 +0.01 / +0.74%
Today’s Change
1.32
Today|||52-Week Range
2.16
-3.52%
Year-to-Date
Why Arena Pharmaceuticals Stock Sank in 2016
Jan 13 / MotleyFool.com - Paid Partner Content
Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
Jan 09 / Zacks.com - Paid Partner Content
VIVUS Licenses Rights to PAH Drugs from Selten Pharma
Jan 11 / Zacks.com - Paid Partner Content
Vertex Pharma Issues Disappointing 2017 Orkambi Outlook
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.36
Today’s open1.35
Day’s range1.34 - 1.40
Volume1,868,378
Average volume (3 months)1,754,068
Market cap$333.3M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-60.71%
Earnings growth (this year)+26.34%
Earnings growth (next 5 years)-45.30%
Revenue growth (last year)+3.67%
P/E ratioNM
Price/Sales11.93
Price/Book6.21

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.08-1.35%
RARXRa Pharmaceuticals I...+0.72+5.12%
ADXSAdvaxis Inc-0.27-3.18%
NLNKNewLink Genetics Cor...+0.54+5.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$38.3M
Annual profit (last year)-$108.0M
Net profit margin-281.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Amit D. Munshi
SVP-Operations &
Head-Global Regulatory Affairs
Craig M. Audet
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs